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OBJECTIVE To gain a better understanding of ice ball dimensions and temperature isotherms relevant for cell
kill when using combinations of cryo-needles we set out to answer 4 questions: (1) what type of
cryo-needle? (2) how many needles? (3) best spatial configuration? and (4) correct duty cycle
percentage?
METHODS We conducted laboratory experiments to monitor ice ball dimensions and create multi-needle
planar isotherm maps for 17G and 10G cryo-needles using a novel multi-needle thermocouple
fixture within gel at body temperature. We tested configurations of 1-4 cryo-needles at duty cycles
of 20%-100% with 1-2.5 cm spacing.
RESULTS Analysis of various combinations shows that a central core of ≤−40°C develops at a distance of
~1 cm around the cryo-needles. Temperature increases linearly from this point to the ice ball leading
edge (0°C), which is a further ≈1 cm away. Thus, the −40°C isotherm is approximately 1 cm inside
the leading edge of the ice ball.
The optimum distance between cryo-needles was 1.5-2 cm, at duty cycle settings of 70%-
100%. At distances further apart or with lower duty cycle settings, ice balls either had a central
core >−40°C or had an hourglass shape.
CONCLUSION In answer to questions 1-3, tumor length, diameter, and shape will ultimately determine the number
of needles and their configuration. However, we propose a conservative distance for cryo-needle
placement between 1 and 1.5 cm should be adopted for clinical practice. In answer to question
4, using low duty cycle settings runs the risk of incomplete −40°C isotherm coverage of the tumor,
and thus in routine practice we suggest that settings of 70%-100% are most appropriate. UROLOGY
91: 234–240, 2016.
Although cryotherapy has been in use for more than50 years, recent advances have allowed it todevelop into a potential treatment for both pros-
tate and renal cancers.1,2 Renal cryotherapy is already con-
ducted in a focal tissue-preserving manner, and increasingly,
cryotherapy is also applied for focal therapy of prostate
cancer.3,4 However, it is still an evolving technique that
is adopted and effective in selected cases with local recur-
rence rates being higher in comparison with conven-
tional radical surgery particularly in higher risk cases. A
recent systematic review of focal prostate cryotherapy con-
firms good short- to medium-term oncological outcomes
with a biochemical disease-free survival of between 71%
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and 93% and a minimal side effect profile for both primary
and salvage cases.5 Renal cryotherapy is generally re-
served for patients with small renal masses who are not suit-
able or unwilling to undergo partial or radical nephrectomy,
and can be performed by either a percutaneous or laparo-
scopic approach.6,7 Oncological outcomes are generally
poorer with cryotherapy compared with partial nephrec-
tomy, with a systematic review finding an increased rela-
tive risk of 9.39 for local progression. However, this was
balanced against a significantly better side effect profile using
cryotherapy.8
Earlier preclinical studies used older systems with liquid
nitrogen as the cooling gas, whereas newer generation
systems use compressed argon for cooling along with helium
for thawing. Although there is extensive literature on the
clinical outcomes of cryotherapy, largely from single-arm
or multicenter registry studies, there is significantly less con-
temporary data evaluating the dynamics of ice ball forma-
tion using modern equipment. Thus, a potential reason for
local recurrence may be the lack of information regard-
ing ice ball isotherms (temperature gradient maps) par-
ticularly using multi-needle configurations, resulting in
imperfect and incomplete cancer tissue ablation.
The developing ice ball normally has a leading edge of
0°C with a colder inner core. This temperature gradient
map across the ice ball is made up of isotherms. Both liquid
nitrogen and argon gas systems are theoretically able to
produce temperatures close to −190°C. However, it is gen-
erally accepted that such low temperatures are not needed
for cell death.
Various studies have assessed a so-called “lethal tem-
perature” where complete cell death via coagulative ne-
crosis is expected to occur. The currently accepted
temperature is −40°C, beyond which further crystalliza-
tion of water does not occur.9,10
To ensure adequate ice ball coverage of the target volume
at a sufficiently low temperature, a surgeon must under-
stand 4 critical variables for the formation of an ice ball,
namely (1) cryo-needle type, (2) number of cryo-needles,
(3) cryo-needle configuration, and (4) duty cycle percent-
age (percentage on-off time).
The aim of our study was to investigate the interaction
of these multiple variables in forming single and multiple
isotherm maps, with the aim of improving pre- and intra-
operative planning using modern cryo-needles and deliv-
ery systems. To do this, we developed a novel method for
accurate testing of ice ball dimensions and isotherms. Sub-
sequent use of these data in developing and improving cryo-
therapy technique may lead to better cancer cell kill and
local control, and subsequently improved oncological
outcomes.
METHODS
Multi-needle Thermocouple (TC) Matrix Structure
A multi-needle TC matrix fixture was constructed from
plastic frames and fine-gauge thermocouple wires to enable
the recording of multiple-needle configuration isotherms.
The exact configuration of the matrix is given in Figure 1.
The placement holes allow for a two-dimensional con-
figuration. The needles can be positioned as desired in the
X-Y plane, which is parallel to the plane of temperature
measurement (the needles are orthogonal to the measure-
ment plane). The Z-axis (insertion depth) position is fixed
to align the center of the ice ball with the measurement
plane. This allowed us to place cryo-needles (each indi-
vidually controlled) in any three-dimensional configura-
tion using placement holes that were spaced every 5 mm
in the X axis and 10 mm in the Y axis (similar to a tem-
plate perineal grid used during cryotherapy) across the
matrix.
Cryo-needles
Three types of cryo-needles were evaluated: the IceSphere
and the IceRod were 1.5 mm (17G) needles often used for
prostate ablation, whereas the IceEdge was a larger 2.4 mm
(10G) needle often used in larger organs such as for renal
ablation (IceEdge). The IceSphere differed from the IceRod
Figure 1. Assembled multi-needle thermocouple (TC) matrix. TC junctions (pink dots) and needle slots (blue dots). (Color
version available online.)
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by having a shorter convective exchange region and thus
would produce an ice ball 1.5 cm shorter in length.
Duty cycle describes the percentage of time cryogen gas
is flowing through the needle. We tested 4 duty cycle set-
tings of 100%, 70%, 50%, and 20%. In addition, needle
configurations with 2, 3, and 4 needles placed at different
spacing was evaluated (1 cm, 1.5 cm, 2.0 cm, and 2.5 cm).
Previous data reported the length of isotherms mea-
sured in gel at 21°C after a standard freezing procedure.11
However, because the body temperature is approximately
37°C, our study was performed in ultrasound (US) gel at
37°C to mimic the body heat load effect.
The single cryo-needle maximum ice ball diameter at
37°C was 3.4-3.6 cm for the 17G needles and 4.3 cm for
the 10G needle. A smaller inner core of ≤−40°C had di-
ameters of 1.8 cm (17G) and 2.4 cm (10G).
Operating Procedure
The tested cryo-needles were placed in US gel at 37°C,
with uniform temperature distribution maintained in the
gel tank. All needles underwent a simultaneous standard
freezing procedure of two 10-minute active argon freeze
cycles separated by a 5-minute passive thaw. During the
test, the planar temperature distribution at the largest ice
plane (middle of the single ice ball height) was recorded
by the multi-needle TC matrix fixture.
The recorded temperature distribution was analyzed to
find and calculate the 0°C, −20°C, and −40°C isotherms
at the center of the ice ball. The calculation was made using
multi-needle analyzer software.
RESULTS
Initial single-needle tests assessing duty cycle percentage
showed that when duty cycle was decreased to 70%, up to
a 10% reduction was seen in the maximum ice ball diam-
eter with an associated 10%-20% decrease in total volume
and area of the −40°C isotherm. This effect was observed
particularly with the 17G cryo-needles. As we dropped the
duty cycle setting further to 50%, an associated 25%-
50% decrease in maximum diameter and a 55%-75%
decrease in volume of the −40°C isotherm were seen. At
a setting of 20%, none of the cryo-needles were able to
produce a −40°C isotherm (Fig. 2).
Subsequent testing of 2 cryo-needle configurations created
either a cylindrical or an oblong ice ball with a maximum
−40°C isotherm diameter of 3.1 cm (IceSphere), 4.2 cm
(IceRod), and 4.7 cm (IceEdge). The 3 cryo-needle con-
figurations created cylindrical ice balls until a distance of
2 cm where a pyramidal shape developed. The maximum
lethal −40°C isotherm diameters were 4.4 cm for the two
17G needles and 4.9 cm for the 10G needle. Four cryo-
needle configurations created larger cylindrical ice balls
whose central core only rose above a temperature of −40°C
at a distance of 2 cm apart, with the lowest duty cycle setting
of 20%. The maximum lethal isotherm diameters were
4.7-5.0 cm for the 17G needles and 6.6 cm for the 10G
needle.
At a duty cycle setting of 100%, all cryo-needle con-
figurations were able to create a confluent central core at
distances of up to 2 cm apart. Only at the lowest duty cycle
setting of 20%, as distance between the needles in-
creased, an hourglass shape (loss of ice ball confluence) de-
veloped with the central core being warmer than the area
closest to the cryo-needle. The most efficient distance for
cryo-needle placement was 1.5 cm for the 17G needles and
2 cm for the 10G needle. The multi-needle maps with a
spacing of 1.5 cm apart with varying duty cycle settings for
the 17G IceRod needle are shown in Figure 3.
Analysis of the various combinations shows that a
central core of ≤−40°C develops very consistently at a
minimum distance of ~1 cm around the perimeter of the
cryo-needles. The temperature increases linearly from
this point to the ice ball leading edge (0°C), which is a
further 0.85-1.15 cm away. Thus, the −40°C isotherm is
approximately 1 cm inside the leading edge of the ice
ball.
Analyzing duty cycle data shows us that, if needed, low
duty cycle settings can be used to create small ice balls,
but in routine practice the optimal is at a duty cycle of 70%-
100%. This maximizes the area of the ice ball and allows
Figure 2. 17G (IceRod), single cryo-needle dimensions with respect to duty cycle settings. (Color version available online.)
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consistent core temperatures of ≤−40°C at most configu-
rations and distances.
DISCUSSION
Although numerous groups have tried gel, ex vivo, and in
vivo modeling of the ice ball, to our knowledge, this is the
first study to investigate so extensively the various ice ball
dimensions and isotherms. This is also the first study to assess
variations in duty cycle settings.
Our results show in all configurations the lethal −40°C
isotherm was formed at a distance of 1 cm from the cryo-
needle(s), and the leading edge of the ice ball was ap-
proximately a further 1 cm away. Single-needle performance
deteriorates significantly at duty cycle settings of ≤50%,
whereas multi-needle configurations have a synergistic effect
with maximum efficiency noted at distances of 1.5 cm apart
for the 17G needles and 2 cm apart for the 10G needle.
A major consideration when testing ice ball isotherms
revolves around the thermal properties of live tissue versus
water, gel, or ex vivo tissue. Many studies have used liver
tissue, and although liver tissue has different thermal char-
acteristics from water, it has been shown that ice balls
created within 37°C water baths are relatively similar in
size to those within the perfused liver.12,13 Also, porcine liver
has been shown to be relatively similar to cancerous tissue.14
Additionally, because of the higher water content of human
tissue, thermal conductivity should not cause a major
problem,9 although this may be different when ablation
occurs near large blood vessels or air (lung) because of a
heat sink effect.15,16
Based on this information, we tested in a gel bath main-
tained at 37°C, which would be similar to but unlikely to
precisely mimic in vivo human prostate or renal tissue.
However, this model did allow us to test numerous com-
binations with relative ease while trying to maintain in vivo
applicability. Performing 156 individual experiments would
have been unfeasible and impractical using porcine models,
and thus we felt that a gel-based model was the best com-
promise with the results and principles of ice ball
isotherm formation still relevant for use in clinical
practice.
Figure 3. 17G (IceRod), 2-needle (top), 3-needle (middle), and 4-needle (bottom) configurations at a spacing distance of
1.5 cm and varying duty cycles. (Color version available online.)
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Reviewing our results shows that they closely resemble
a smaller study by Weld et al in live porcine kidneys.17 The
authors also noted a synergistic effect with multiple cryo-
needles, and to ensure a 1-cm margin, more than 1 needle
needed to be used. Our data using the 17G IceRod 2 cm
apart show that the lethal isotherm defined at −40°C was
1.8 cm using 1 needle, 4.4 cm using a 3-needle combina-
tion, and 5 cm using a 4-needle combination—this closely
resembles their histologic ablative dimensions. We also
found that the optimum distance between needles to maxi-
mize the ice ball area should be 1.5-2 cm, and a study in
live porcine renal tissue has shown a similar result.18
A previous work by Saliken et al noted that the central
core takes longer to fuse and may have lower tempera-
ture, which needs to be accounted for during clinical
practice.19 Our results confirm this finding that when cryo-
needles are further apart, a central core forms, which may
not be at or below the lethal temperature of −40°C.
Another factor to be considered is the uniformity of the
ice ball. Although we did not notice this phenomenon in
our experiments, others have found that the lethal tem-
perature is not always uniform around the needles, and thus,
it seems that for accurate in vivo lethal isoform measure-
ments, multiple thermocouples should be routinely used.20
The distance of the leading edge from the lethal iso-
therm is also important and similar to a work by Littrup
et al; in agar gel phantoms, they found that the lethal iso-
therm is smaller than total ice ball formed.21
Thus, when applying our results and also data from the
reviewed literature into clinical practice, there are 4 factors
that a surgeon needs to consider when performing cryo-
therapy, particularly with regard to the treatment field and
ice ball configuration. The first is the type of cryo-needle
used, and with regard to the prostate, the craniocaudal (base-
apex) length of the prostate will ultimately determine the
type of needle used. The length of the ice ball should not
extend beyond the apex as this may increase the risk of
injury to the urethral sphincter. With regard to the kidney,
the maximum length of the tumor will determine which
needle should be used.
As our results have shown, either focal or, if needed, large
ice balls can be created by varying the remaining three
factors: number of cryo-needles, needle configuration, and
duty cycle percentage. Using this data set, a surgeon can
accurately determine preoperatively which combination of
factors he or she needs to cover his or her target lesion.
Similar to the ice ball length, the diameter of the tumor
will determine the number of needles needed along with
their exact configuration. However, as a general rule, we
found the optimum distance for cryo-needle placement to
be between 1.5 and 2 cm. Although our data appear com-
parable with live porcine experiments, as our data are not
in human tissue, it would be reasonable to use a more con-
servative distance of 1-1.5 cm, which would balance ice
ball volume and cell kill temperatures. As mentioned pre-
viously, manipulation of duty cycle settings can allow further
changes in ice ball size, but with low duty cycle settings,
the risk of incomplete coverage of the tumor by the −40°C
isotherm increases and thus in routine practice we feel that
a setting of 70%-100% is most appropriate.
Intra-operative imaging is also an important factor to
consider. In renal cancer, percutaneous surgery allows for
direct visualization under computed tomography and mag-
netic resonance (MR).22 The growing low-attenuation lesion
has been shown to closely resemble the leading edge (0°C)
of the ice ball, whereas MR images provide a superior con-
trast between the ice ball and the surrounding tissue.23 Al-
though in-bore MR techniques exist for the prostate, they
are not practical, and thus US is our chosen modality for
intra-operative imaging. However, as the US probe is located
transrectally, once the ice ball starts to develop, the an-
terior aspect of the ice ball is no longer visible because of
the acoustic shadow cast by its leading edge. It must also
be noted that the lethal temperature isotherm may be up
to 1 cm beneath this leading edge. As neither computed
tomography nor US can predict an ice ball isotherm, MR
has a significant advantage in this area.
Use of data such as these can help rationalize the number
of needles needed to allow adequate coverage of a tumor
in either focal or whole-gland prostate or renal cryoablation.
With the development of US fusion systems for prostate
cancer, further preoperative optimization can be per-
formed by preselecting the needle positions. We have high-
lighted a case of prostate cancer where use of our data has
allowed accurate preoperative planning of needle number,
configuration, and duty cycle settings, along with intra-
operative use of the Biojet US fusion system24 (Fig. 4).
There are, however, some potential limitations in our
study that must be highlighted. First, a gel model at 37°C
is not human tissue, and the thermal properties may vary.
Second, we have not accounted for variations in vascular
anatomy or tested configurations around the urethral warmer
during prostatic procedures. However, our data might allow
significant pre- and intra-operative decisions to be made
in the delivery of cryotherapy for ablation of soft-tissue
tumors and is the only study of its kind assessing such a
large combination of factors. Designing an experimental
model to accurately assess all possible combinations of the
variables is a challenge. The ideal study would allow real-
time monitoring of the ice ball in patients undergoing treat-
ment followed by histologic assessment of the treated lesion.
However, because of the number of combinations and
ethical considerations needed, this scenario is very diffi-
cult if not impossible to create. Third, we also did not assess
temperature drop in relation to duration of freeze cycle and
used the currently accepted protocol of two 10-minute freeze
cycles separated by a 5-minute passive thaw.
We have tried to build an accurate gel model based on
the literature, and it appears that our results do compare
well with other in vivo studies. Future work will need to
focus on modeling ice balls around structures that may lead
to a heat sink effect, such as blood vessels and urethral
warming catheters. Additionally, there is growing evi-
dence that cryotherapy can lead to both immune stimu-
latory and inhibitory effects. There may be surgical factors
that influence this phenomenon, and Urano et al showed
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Figure 4. (A) Multi-parametric magnetic resonance imaging showing 18 mm max. diameter anterior prostate cancer.
(B) Overlaid ice ball data, 1 cm apart at a duty cycle of 100% showing adequate coverage by −40°C isotherm over lesion.
(C) Intra-operative needle placement using Biojet ultrasound (US) fusion system. (D) Intra-operative ice ball expansion.
(E) Dynamic contrast enhanced magnetic resonance (MR) images showing area of necrosis and concordance with preop-
erative planning. (Color version available online.)
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that treatment of single rather than multiple lesions within
the liver resulted in the largest immune response.25 Addi-
tionally, a study on a rat breast carcinoma cell line sug-
gested that the immune response decreased as a larger bulk
of tissue was frozen.26 Development of animal models in
the future, which allow in vivo testing of numerous ice ball
configurations, may allow us to gain a further insight into
this phenomenon.
CONCLUSION
We set out to answer 4 questions: (1) What type of cryo-
needle should be adopted? (2) How many needles should
be used? (3) Which is the best spatial needle configura-
tion? and (4) Which is the correct duty cycle percentage?
To answer questions 1-3, the length, diameter, and shape
of the tumor will ultimately determine the number of
needles needed along with their exact configuration. Our
results show that the −40°C lethal isotherm is approxi-
mately 1 cm inside the leading edge of the ice ball. The
optimum distance between cryo-needles was 1.5-2 cm, at
duty cycle settings of 70%-100%. At distances further apart
or with lower duty cycle settings, ice balls had either a
central core >−40°C or an hourglass shape. However, con-
sidering that our results are not within live tissue, we feel
that a more conservative distance for cryo-needle place-
ment between 1 and 1.5 cm should be adopted for clini-
cal practice.
To answer question 4, although the use of low duty cycle
settings is possible, it runs the risk of incomplete cover-
age of the tumor by the −40°C isotherm, and thus in routine
practice we feel that a setting of 70%-100% is most
appropriate.
We have presented a large amount of experimental data
on ice ball isotherms, which can aid a surgeon in opera-
tive planning with regard to needle placement and duty
cycle settings to ensure that the lethal isotherm of −40°C
adequately covers the tumor.
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APPENDIX
SUPPLEMENTARY DATA
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.urology.2016.02.012.
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